Cytochrome P450 (P450) enzymes have been shown to detoxify and/or toxify compound which are more polar and sometimes more reactive metabolites. Therefore, it is interesting to examine how (Ϫ)-camphor is metabolized by P450 in human liver microsomes.
There are several reports on the biotransformation of (Ϫ)-camphor by microorganisms. Metabolism of (Ϫ)-camphor in mammals, microorganism and plant cells have been published, e.g. dogs, 3, 4) rabbits, 4) Pseudomonas putida, [5] [6] [7] [8] [9] [10] [11] Streptomyces griseus 12) the S. officinals [13] [14] [15] and Eucalyptus perriniana. 16) We recently established the biotransformation of (ϩ)-and (Ϫ)-camphor by Spodoptera litura (a species of caterpillar). 17) However, there have been no reports on the biotransformation of (Ϫ)-camphor by the human body.
We previously reported that 1,4-cineole, 1,8-cineole, (ϩ)-and (Ϫ)-limonene enantiomers and (Ϫ)-verbenone, compounds present in nature, are metabolized by different forms of P450 enzymes in human. [18] [19] [20] [21] 1,4-Cineole and 1,8-cineole are both principally oxidized by CYP3A4 in humans, 18, 19) (ϩ)-and (Ϫ)-Limonene are metabolized by CYP2C9 and CYP2C19 in humans, 20) and a (Ϫ)-verbenone is oxidized by CYP2A6 and CYP2B6 in humans. 21) In the current study, we examined the oxidations of (Ϫ)-camphor by P450 enzymes in liver microsomes prepared from different human samples and the metabolites formed were analyzed by GC-MS. To determine which P450s are the major enzymes responsible for the oxidation of (Ϫ)-camphor, we used specific P450 inhibitors and antibodies raised against purified human liver P450 enzymes. Catalytic rates of (Ϫ)-camphor oxidation with eleven forms of human P450 enzymes expressed in baculovirus-infected insect cells are also reported.
MATERIALS AND METHODS

Chemicals (ϩ)-Menthofuran, NADP
ϩ , glucose 6-phosphate, and glucose 6-phosphate dehydrogenase were purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.). (Ϫ)-Camphor (purity, Ͼ99%) was purchased from Fluka. 5-exo-Hydroxycamphor (purity, Ͼ99%) was isolated from Spodoptera litura. 17) Other reagents and chemicals used in this study were obtained from sources described previously or were of the highest quality commercially available. Enzymes and Antibodies Human liver microsomes were obtained from BD Gentest Corporation (Woburn, MA, U.S.A.) (HG23, HG03, HH18, HG88, HG74, HG06, HK37, HH13, HG56) where they were stored at Ϫ80°C. Liver microsomes were prepared as described and suspended in 10 mM Tris-HCl buffer (pH 7.4) containing 1.0 mM EDTA and 20 % glycerol (v/v). 22, 23) Recombinant CYPs1A1, 1A2, 1B1, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, 3A4 were expressed in baculovirus-infected insect cells were obtained from BD Gentest, and the P450 contents in these systems were used as described in the data sheets provided by the manufacturer. Control serum and rabbit anti-human CYP2A6 antibody was obtained from Nihon Nosan Kogyo KK.
Assay (Ϫ)-Camphor hydroxylation activities by P450 enzymes were determined as follows. Standard reaction mixture contained human liver microsomes (0.1 mg/ml) or recombinant P450 (10 pmol/ml) with 100 mM potassium phosphate buffer (pH 7.4) containing an NADPH-generating system consisting of 0.5 mM NADP ϩ , 5 mM glucose 6-phosphate, and 0.5 unit of glucose 6-phosphate dehydrogenase/ ml, 100 mM (Ϫ)-camphor dissolved in methanol (at 0.2% v/v in final solvent concentration) in a total volume of 0.5 ml. Incubations were carried out at 37°C for 30 min and terminated by the adding 1.5 ml of dichloromethane. The mixtures were mixed vigorously and the extracts (organic layer) collected by centrifugation at 3000 rpm for 5 min. The organic phase was transferred to an insert for analysis by gas chromatography-mass spectrometry.
GC-MS A Hewlett-Packard model 5890A gas chromatograph equipped with a split injector was directly coupled to a Hewlett-packard 5972 mass spectrometer. The metabolites were separated with a DB-5 silica capillary column (0.25 mmϫ30 m) using He (at 1 ml/min) as a carrier gas. The column temperature was programmed from 65 to 240°C at the rate of 4°C/min and then held at 240°C for 10 min. The injector temperature was maintained at 240°C. Detector interface temperature was 280°C, with the actual temperature in the MS source reaching approximately 240°C and an ionization voltage of 70 eV.
Inhibition of (؊)-Camphor Metabolism by Chemical Compounds
Inhibition experiments started with a 10-min preincubation at 37°C of 0.1 mg microsomal protein (HG03), 2.5, 5, 10, 20 mM (ϩ)-menthofuran which was dissolved in methanol, 100 mM potassium phosphate buffer (pH 7.4) containing an NADPH-generating system consisting of 0.5 mM NADP ϩ , 5 mM glucose 6-phosphate, and 0.5 unit of glucose 6-phosphate dehydrogenase/ml. After preincubation, 100 mM (Ϫ)-camphor dissolved in methanol (at 0.2% v/v in final solvent concentration) was added. Incubations were carried out at 37°C for 30 min and terminated by adding 1.5 ml of dichloromethane. The mixtures were mixed vigorously and the extracts (organic layer) collected by centrifugation at 3000 rpm for 5 min. Two control experiments were carried out under the same conditions, but neither with (ϩ)-menthofuran.
RESULTS
Identification of (؊)-Camphor Metabolites When Incubated with Human Liver Microsomes (Ϫ)-Camphor was incubated with liver microsomes of human sample HG-03 in the presence of an NADPH-generating system and the products thus formed were analyzed by GC-MS as follows (Figs.  1, 2) .
Peak 1: The molecular mass of the metabolite increased from 152 to 168. GC-MS showed an abundance of mass (66)] and the retention time of the metabolite was 23.8 min. Identity of the metabolite was confirmed by a comparison with the authentic reference compound. These results collectively identified the metabolite as 5-exo-hydroxycamphor that has been isolated from biotransformation products of (Ϫ)-camphor with Spodoptera litura. 17) On incubation of (Ϫ)-camphor with human liver microsomes in the presence of an NADPH-generating system, the formation of 5-exo-hydroxycamphor metabolite increased with increasing incubation time (Fig. 3) .
Role of Human CYP2A6 in the Hydroxylation of (؊)-Camphor Recombinant human P450 enzymes expressed in baculovirus-infected insect cells were tested for their catalytic activities to catalyze (Ϫ)-camphor oxidation. Among the eleven human P450 enzymes examined in this study, CYP2A6 was found to hydroxylate (Ϫ)-camphor to the 5-exo metabolites at a turn over rate of 4.9 nmol/min/nmol P450. Other recombinant human P450 including that including CYP1A1, CYP1A2, CYP1B1, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1 and CYP3A4 did not catalyze the hydroxylation of (Ϫ)-camphor (Fig. 4) . Anti-CYP2A6 inhibited (Ϫ)-camphor as in human liver microsomes. (R)-(ϩ)-Menthofuran, an inhibitor of CYP2A6 inhibited (Ϫ)-camphor 5-exo-hydroxylation catalyzed by human liver microsomes (Fig. 5) .
Correlation between Contents of CYP2A6 and (؊)-Camphor Oxidase Activities 9 Human Liver Microsome Samples
The above results suggested that CYP2A6 is an important enzyme in (Ϫ)-camphor oxidation by human liver microsomes. Correlation between contents of CYP2A6 and rates of formation of 5-exo-hydroxycamphor were compared in liver microsomes from 9 human samples. The mean levels of CYP2A6 in the samples were estimated to be 12.5Ϯ 10.1 pmol/mg of protein (10.2Ϯ6.6% of total P450). We found there were good correlations between CYP2A6 levels and the formation of 5-exo-hydroxycamphor (rϭ0.954; pϽ 0.001) (Fig. 6) .
Kinetic Analysis of (؊)-Camphor Hydroxylation by Human Liver Microsomes, CYP2A6 Kinetic analysis of the (Ϫ)-camphor hydroxylation activities was examined in liver microsomes (human sample HG-03). K m and V max values were 41 mM and 1.24 nmol/min/nmol P450. Kinetic analysis was also perfomed in recombinant CYP2A6 in the oxidations of (Ϫ)-camphor. K m values for the formation of 5-exo-hydroxycamphor in CYP2A6 was 23 mM, and V max values were 4.9 nmol/min/nmol P450 (Table 1) .
DISCUSSION
Various monoterpenoids, including camphor, have been reported to be biotransformed by several biocatalysts. We have previously shown that camphor is metabolized by Spodoptera litura to 5-exo-hydroxycamphor, 5-endo-hydroxycamphor and 8-hydroxycamphor as a major metabolite. 17) Additional studies have indicated that Pseudomonas putida converts camphor to 8-hydroxycamphor. [5] [6] [7] [8] [9] [10] [11] Also, oxidation of (ϩ)-camphor by cytochrome P-450 soy-enriched intact cells of Streptomyces griseus resulted in the formation of one major and several minor metabolites. The major metabolite was identified as 6-endo-hydroxycamphor, while the minor metabolites were identified as 3-endo-, 5-endo-, 5-exo-hydroxycamphor, 2,5-diketobornane and camphorquinone. 12) In mammalian species, the metabolism of (ϩ)-and (Ϫ)-camphor has been studied in the dog and rabbit in vivo and in liver preparations from rats and rabbits in vitro. However, it remains unclear whether camphor is metabolized in humans.
The metabolism of (Ϫ)-camphor by human liver microsomal P450 enzymes has been studied and we have confirmed the formation of 5-exo-hydxylated metabolites (Fig. 2) . CYP2A6 was identified as a major enzyme involved in (Ϫ)-camphor 5-exo hydroxylation by human liver microsomes according to the following lines of evidence. (ϩ)-Menthofuran and anti-CYP2A6 significantly inhibited (Ϫ)-camphor hydroxylation and there was a good correlation between (Ϫ)-camphor 5-exo hydroxylation activities and CYP2A6 in liver microsomes of 9 human samples. Kenneth et al. described the metabolism of camphor in rats and rabbits in vitro. In rats, the major products appeared to be the same three hydroxylation products as were excreted by the dog 3) : 3-hydroxycamphor, 5-exo-and 5-endo-hydroxycamphor. Metabolites in rabbit liver microsomes were similar to those obtained in the analogous rat liver microsomes, except that the ratio of endo-and exo-isomers of 5-hydroxycamphor produced from camphor was higher than in the rat liver preparation. 3, 4) In human liver microsomes, 5-exo-hydroxycamphor was detected only an oxidation product. These results suggested that there are species-related differences in the metabolism of camphor to 3-hydroxycamphor, 5-exo-and 5-endo-hydroxycamphor by P450 enzymes in rats, rabbits and humans.
In summary, our current results have demonstrated that (Ϫ)-camphor is oxidized to 5-exo-hydroxyfenchone derivatives in human liver microsomes. CYP2A6 is suggested to be a principal enzyme in catalyzing (Ϫ)-camphor 5-exo hydroxylation by these human liver microsomes. 
